外来高血圧バンドルに対するクリニックの忠実性をサポートするための検査実施戦略 (ACHIEVE)
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle: ACHIEVE (Advancing Community and Clinical Care for Childbirth-related Hypertension Through Implementation, Engagement, and Valuing Everyone)
The goal of this clinical trial is to test an approach to improve care for pregnant and post-partum patients with high blood pressure. The study participants are providers and staff in prenatal care clinics, and the condition of interest is severe hypertension. The research questions are:
- Does the ACHIEVE intervention increase the quality and accuracy of measuring patient blood pressure?
- Does the ACHIEVE intervention increase the documentation of delivery of patient education on hypertension?
- Does the ACHIEVE intervention result in better recognition and treatment of severe hypertension during practice sessions (simulations)?
- Does the ACHIEVE intervention result in better recognition and treatment of severe hypertension for patients who come to the clinic?
Participants from outpatient prenatal care clinics in North Carolina will work with an ACHIEVE Nurse Coordinator who will deliver training, coaching, simulations, and educational materials. Three groups of clinics will be phased into Active Implementation every six months. The study team will examine data collected before, during, and after the intervention to see if the results show improvement.
調査の概要
詳細な説明
New or worsening high blood pressure in pregnancy can develop into a disease called preeclampsia. If left untreated, preeclampsia may turn into eclampsia. Eclampsia occurs when a pregnant person has a seizure or a stroke, which can lead to lifelong health problems, or even death. In 2018, 14% of pregnant people who gave birth in North Carolina experienced high blood pressure. Rural, low-income, and women of color are at greatest risk for complications of high blood pressure in pregnancy and postpartum. These same individuals also face challenges in accessing care. To improve maternal health outcomes for these patients, the Alliance for Innovation on Maternal Safety (AIM) developed the Severe Hypertension During Pregnancy and Postpartum Period Safety Bundle (HTN bundle) which includes five areas of focus: (1) Readiness of clinics to change practices (2) Recognition of high blood pressure (3) Response to patients with high blood pressure during pregnancy or postpartum; 4) Reporting/Systems Learning to track data related to clinic changes and (5) Respectful Care to ensure equity and respect in care of patients. Initially released in 2015, The HTN bundle has been used by hospitals to improve recognition and treatment of high blood pressure in birthing people. The ACHIEVE (Advancing Community and Clinical Care for Childbirth-related Hypertension through Implementation, Engagement, and Valuing Everyone) Initiative was developed to support outpatient clinics in providing more effective care to pregnant individuals with high blood pressure. Adapting this bundle for community clinics providing pregnancy care has the potential to reach more birthing people outside the hospital setting who are most vulnerable to complications.
In the initial phase of ACHIEVE, the study team partnered with three rural Piedmont Health Services (PHS) clinics that serve mostly White and Latinx patients. The inpatient HTN bundle was adapted to fit their setting and re-named the Outpatient Hypertension (O-HTN) bundle. Additionally, a coalition was established to engage patients, clinic providers/staff, and the broader community to: (a) understand factors influencing maternal health including economic stability, education, health care access, and community context, (b) assess what makes it easier or harder to implement the O-HTN bundle in community outpatient clinic settings, (c) adapt the O-HTN bundle to fit those settings and populations, and (d) select and tailor changes to clinic practices using continuous cycles of learning, measuring and adapting to be the most effective and sustainable for the organization. Building on this formative work, the goal of the clinical trial is to determine the impact of four implementation strategies (training, coaching, facilitation, educational materials) in up to 20 outpatient clinics in central North Carolina. Usual clinic care for severe hypertension will be compared to the care provided after a practice has 12 months of implementation support from the ACHIEVE Nurse Coordinator. ACHIEVE partners include healthcare leadership, clinic providers and staff, community-based organizations, and individuals with lived experience who will work together on this project. If the project succeeds in improving care, the ACHIEVE model will be shared across the state and nationally to support healthier birthing people and communities.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究場所
-
-
North Carolina
-
Burlington、North Carolina、アメリカ、27215
- Cone Health
-
Burlington、North Carolina、アメリカ、27217
- Alamance County Health Department
-
Chapel Hill、North Carolina、アメリカ、27516
- The University of North Carolina at Chapel Hill
-
Chapel Hill、North Carolina、アメリカ、27514
- Piedmont Health Services
-
Chapel Hill、North Carolina、アメリカ、27514
- Unified Women's Healthcare of the Carolinas
-
Durham、North Carolina、アメリカ、27710
- Duke University Health System
-
Hillsborough、North Carolina、アメリカ、27278
- Orange County Health Department
-
Raleigh、North Carolina、アメリカ、27610
- WakeMed
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
INCLUSION CRITERIA
-
Sites/Facilities Enrolling Participants
The prenatal care clinics being recruited must meet all of the following inclusion criteria:
- Physical location of the clinic is in Orange, Alamance, Durham, or Wake County
- The clinic patient population includes ≥ 50 births per year
- The clinic uses an electronic health record system
Additionally, the clinic's patient population must meet one or more of the following inclusion criteria:
- ≥ 50% uninsured or insured by Medicaid
- ≥ 20% Black / African American
- ≥ 20% rural residents
-
Clinic Participants
Participants will include volunteers within the following categories:
a. Implementation Team b. Care Team c. Medical Support Personnel
-
Patients (Patient Education Cohort)
- Gave birth up to six months prior to the data collection timepoint
- Received at least two or more prenatal care visits from the participating clinic
- At least one of the two prenatal care visits must occur between 20- and 34-weeks gestation
-
Patients: (Timely Delivery of Care Cohort)
- >20 weeks pregnant or up to six weeks post-partum in the 12 months prior to the data collection timepoint
- Had at least one documented episode of severe hypertension (systolic blood pressure of 160 mmHg or higher, or diastolic blood pressure of 110 mmHg or higher) during a visit encounter with a participating clinic
- Individual pregnant or postpartum people should have all episodes included if they present with severe range blood pressures more than once on different days
EXCLUSION CRITERIA
-
Sites/Facilities Enrolling Participants
- Clinics that were part of the Pilot Phase of this study
- Clinics that had recently completed a similar quality improvement project focused on severe hypertension
-
Implementation Team
- Provider cannot be a Medical Resident
-
Care Team
a. Provider cannot be a Medical Resident
-
Medical Support Personnel
a. None
-
Patients (Patient Education Cohort)
a. None
-
Patients (Timely Delivery of Care Cohort) a. None
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:非ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
プラセボコンパレーター:Usual Care Arm
The Usual Care Arm is comprised of the clinics that are not yet receiving the intervention. All clinics participating in the study are in the Usual Care Arm until they begin the Active Implementation phase. |
All clinics in North Carolina Perinatal Region IV have access to Severe HTN Bundle resources on the AIM website (https://saferbirth.org/psbs/severe-hypertension-in-pregnancy) and the locally adapted Outpatient HTN Bundle resources on the North Carolina Perinatal Region IV Provider Support Network website (https://www.mombaby.org/outpatient-bundle-for-severe-hypertension/). At baseline, the clinical leadership of all enrolled sites will receive direct communication via email that describes and provides links to the available resources. This will constitute "usual care." |
|
アクティブコンパレータ:Active Implementation Arm
The Active Implementation Arm is comprised of the clinics that have started to receive the intervention, which is the ACHIEVE multi-component implementation strategy delivered by the Nurse Coordinators. All clinics (divided into 3 Cohorts) move from the Usual Care Arm into the Active Implementation Arm in sequential order (six months apart). |
The intervention is comprised of four implementation strategies: facilitation/coaching, training, simulation, and delivering educational materials. The ACHIEVE study team, primarily the Nurse Coordinator, will engage teams within each clinic to participate in quality improvement activities utilizing these four strategies. The Nurse Coordinator will train the providers/staff on the O-HTN bundle components, facilitate corresponding office systems and workflow changes, and conduct simulations of patients with severe hypertension so care teams can practice the steps involved in recognizing and responding to episodes of severe hypertension in a timely manner. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Normalized percentage of achieving the highest possible score for blood pressure measurement technique
時間枠:Up to 48 months
|
Derived from an 11-item observation checklist with a maximum score of 11 points per observation (sample: all Medical Support Personnel who are trained to measure blood pressure for prenatal patients). The construct is fidelity to blood pressure measurement technique; a higher score represents an improvement in fidelity; the range for the checklist is 0-11 which will be translated into a normalized percentage from 0-100. |
Up to 48 months
|
|
Normalized percentage of achieving the highest possible score for documentation of delivery of patient education on hypertension.
時間枠:Up to 48 months
|
Derived from retrospective chart audits using a chart abstraction tool and scoring system with a maximum score of 2 points per chart (sample: 25 charts per clinic randomly selected from all pregnant patients who delivered up to 6-months prior to the data collection timepoint). The construct is fidelity to the patient education protocol; a higher score represents an improvement in fidelity; the range for the score is 0-2 which will be translated into a normalized percentage from 0-100. |
Up to 48 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Normalized percentage of achieving the highest possible score for recognition and response to simulated episodes of severe hypertension
時間枠:Up to 13 months
|
Derived from a 5-item checklist with a maximum score of 5 points per simulation (sample: all care teams in clinics that provide prenatal care.) The outcome measure will be assessed at the beginning, middle, and end of the Active Implementation phase. The construct is fidelity to recognition and response to simulated episodes of severe hypertension; a higher score represents an improvement in fidelity; the range for the checklist is 0-5 which will be translated into a normalized percentage from 0-100. |
Up to 13 months
|
|
Normalized percentage of achieving the highest possible score for recognition and response to actual episodes of severe HTN
時間枠:Up to 36 months
|
Derived from retrospective chart audits using a chart abstraction tool and scoring system with a maximum score of 4 points per episode (sample: all episodes of severe HTN among patients who were >20 weeks pregnant or up to six weeks postpartum and received prenatal care from a participating clinic in the 12 months prior to the data collection timepoint). The outcome measure will be assessed in the 12 months before, during, and after the Active Implementation phase. The construct is recognition and response to actual episodes of severe hypertension; a higher score represents an improvement in fidelity; the range for the score is 0-4 which will be translated into a normalized percentage of 0-100. |
Up to 36 months
|
協力者と研究者
協力者
捜査官
- 主任研究者:Mary K Menard, MD, MPH、University of North Carolina, Chapel Hill
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 23-0968
- OT2HL158287 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Data that will be generated from our project will contain PHI. Based on ethical considerations and the need to protect the confidentiality of participants, we expect to produce the following public-use data sets to be preserved and shared:
- Data on fidelity to protocols for Blood Pressure Measurement (observations of medical support personnel)
- Data on fidelity to protocols for Patient Education (retrospective chart audits)
- Data on fidelity to protocols for Recognition and Response to Episodes of Severe Hypertension (observations of care teams during simulations)
- Data on fidelity to protocols for Recognition and Response to Episodes of Severe Hypertension (retrospective chart audits)
Data will be aggregated at the clinic level and reported for each measurement time period. Data will include fidelity to each element of the protocol and an overall score. Clinics will be de-identified.
IPD 共有時間枠
Publicly available data from ACHIEVE will be stored in the UNC DataVerse, a trustworthy, generalist data repository managed by theResearch Data Management Core (RDMC) at the University of North Carolina at Chapel Hill. Data will be available no more than 9 months after publication. The data will be shared and preserved for ten years, per the RDMC retention policy for UNC Dataverse.
IPD 共有アクセス基準
There are no anticipated factors or limitations that will affect the access, distribution or reuse of the scientific data generated by the proposal.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。